Atlas Trials

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Clinical trial NCT01918852 · COMPLETED

Trial details

NCT number
NCT01918852
Sponsor
Dutch Colorectal Cancer Group
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Colorectal CancerMetastases
Start date
2013-12-01
Primary completion
2015-12-01
Enrollment
161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.